ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $309,293 | +415.8% | 46,313 | +548.0% | 0.00% | – |
| Q2 2023 | $59,962 | -15.5% | 7,147 | 0.0% | 0.00% | – |
| Q1 2023 | $70,969 | +41.9% | 7,147 | +0.0% | 0.00% | – |
| Q4 2022 | $50,000 | +28.2% | 7,146 | -2.3% | 0.00% | – |
| Q3 2022 | $39,000 | +30.0% | 7,314 | 0.0% | 0.00% | – |
| Q2 2022 | $30,000 | +650.0% | 7,314 | +798.5% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 814 | +0.4% | 0.00% | – |
| Q4 2021 | $4,000 | -33.3% | 811 | +3.6% | 0.00% | – |
| Q3 2021 | $6,000 | -40.0% | 783 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | -16.7% | 783 | -21.7% | 0.00% | – |
| Q1 2021 | $12,000 | +140.0% | 1,000 | +26.7% | 0.00% | – |
| Q4 2020 | $5,000 | -16.7% | 789 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | +200.0% | 789 | +57.8% | 0.00% | – |
| Q2 2020 | $2,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
| Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
| 683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
| Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
| MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
| Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
| WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
| Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
| ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |